Author:
Dayer P.,Balant L.,Courvoisier F.,Kupfer A.,Kubli A.,Gorgia A.,Fabre J.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference17 articles.
1. Kilborn J.R., Turner P. (1974): Ro 3–4787, a new β-adrenoceptor blocking agent: studies in normal volunteers. Br. J. clin. Pharmac.1, 143–149.
2. Tschopp J.M., Gorgia A., Balant L., Revilland C., Francis R.J., Fabre J. (1978): Rôle des métabolites dans les relations entre la pharmacocinétique et l’effet des agents β-bloquants. Expériences avec le tolamolol et le bufuralol. Schweiz, med. Wschr.108, 756–764.
3. Francis R.J., Allen J.G., East P.B., Ruane R.J. (1976): The metabolism of bufuralol: urinary metabolite profiles in rat, dog and man. Europ. J. Drug. Metab. Pharmacokin.1, 113–124.
4. Francis R.J., East P.B., McLaren S.J., Larman J. (1976): Determination of bufuralol and its metabolites in plasma by mass fragmentography and by gas chromatography with electron capture detection. Biomed. Mass. Spectrom.3, 281–285.
5. Balant L., Francis R.J., Tschopp J-M., Tinguely D., Estreicher J., Fabre J. (1978): Pharmacocinétique du bufuralol chez l’homme. Pharm. Acta Helv.53, 307–313.
Cited by
78 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献